PPCB·74346N701·US·equity·Healthcare - Biotechnology-13D/G
PPCB (PROPANC BIOPHARMA INC) is held by 5 institutional investors as of Q1 2026. Largest holders: UBS Group AG ($19,357), JANE STREET GROUP, LLC ($15,180), Marex Group plc ($7,179). Net institutional sentiment: Mixed.
See how PPCB's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer